EP Patent

EP0924519B1 — Verfahren zur Ermittlung eines Dosierungsschemas für Thrombininhibitoren

Assigned to Abbott GmbH and Co KG · Expires 2006-01-04 · 20y expired

What this patent protects

Patent listed against Dexilant.

Drugs covered by this patent

Patent Metadata

Patent number
EP0924519B1
Jurisdiction
EP
Classification
—
Expires
2006-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Abbott GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.